Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Firefly BioWorks Inc.

Latest From Firefly BioWorks Inc.

Deals In Depth: January 2015

In a deal worth over $1 billion, Depomed got US rights to Janssen's pain drug Nucynta; Roche bought the majority stake in Foundation Medicine. FOPOs drove a large part of biopharma financing.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, February 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2014-January 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Firefly BioWorks Inc.
  • Senior Management
  • Davide M Marini, PhD, CEO & Co-founder
    Daniel C Pregibon, PhD, CTO & Co-founder
    Isaac B Stoner, VP, Product Dev
    Andrea K Bryan, PhD, Dir. Engineering
    Jessica Tytell, PhD, Senior Dir. LifeSci Innovation
    Conor Rafferty, PhD, VP, Research
  • Contact Info
  • Firefly BioWorks Inc.
    Phone: (888) 240-7789
    One Kendall Square
    Bldg 1400W,3 FL
    Cambridge, MA 02139